In a first, India is set to get its first vaccine against cervical cancer on September 1. As per media reports the Serum Institute of India (SII) and the Department of Biotechnology (DBT) will introduce the first domestically produced quadrivalent human papillomavirus vaccine (qHPV) against cervical cancer. The most awaited vaccine will be launched by the Union Minister of State (Independent Charge) Science & Technology Jitendra Singh on Thursday.
Significant for India
According to the World Health Organisation (WHO), one-fifth of the world’s cervical cancer cases are reported in India. India has about 1.22 lakh cases and 67,000 deaths due to cervical cancer every year. It is the third most common cancer in India and the second most common in women aged 15-44 years, according to the Ministry of Health. According to the Centers for Disease Control and Prevention, all women are at risk for cervical cancer. It occurs most often in women over age 30.
Vaccine efficacy claim
The Union health ministry claims that the vaccine will be effective in fighting cervical cancer. Dr. NK Arora, chief of the National Technical Advisory Group on Immunisation (NTAGI), said: “It is very effective and prevents cervical cancer because, 85% to 90% of cases, cervical cancer is because of this particular virus and this vaccine is against those viruses. So, if we give it to our young children and daughters, they are protected from the infection and consequently probably 30 years later, cancer does not occur,” Dr Arora further explained. “In fact, this is one of the last major vaccines to be introduced. In fact, this is one of the last vaccines that will be launched in the programme. Now, Indian vaccines will be available and we hope that it will be launched in the National Immunisation programme for 9-14-year-old girls,” he added.
Vaccine to be low-cost and affordable
The DBT-SII vaccine will prevent women against 6,11,16 and 18 strains by generating antibodies against HPV, Hindustan Times reported. The current vaccine regimens available in India from international pharmaceutical companies cost between Rs. 5,000-8,000. According to DBT, the made-in-India vaccine will be low-cost and affordable and will be especially useful for 50 million girls aged 9-14 years in India.
Indigenously developed vaccine to fulfill local demands
It is a locally manufactured vaccine which will help deal with the global market shortage. “We will be able to take care of our requirements with our made-in-India vaccine, Dr. Arora said. WHO’s 2030 cervical cancer elimination strategy targets say that 90% of girls should be immunized with the HPV vaccine by the age of 15. Dr Arora noted that there was a shortage in the global market. Indian vaccination has now arrived. Consequently, it will be able to meet the needs of the made-in-India vaccine. – INDIA NEWS STREAM
Indian-origin researcher unravels link between depression and heart disease
New Delhi: Depression and cardiovascular disease (CVD) partly develop from the same gene module, said a team of researchers establishing the long-presumed link between the two conditions. Since the 1990s,...
Kejriwal administered insulin in Tihar: AAP
New Delhi: Incarcerated Delhi Chief Minister Arvind Kejriwal was given insulin in Tihar jail for the first time after ED arrest, AAP sources said on Tuesday. “Kejriwal's sugar level was...
From breast cancer to brain, DNA damage – here’s how ethylene oxide can affect your health
New Delhi: Ethylene oxide is a cancer-causing agent that can raise the risk of breast cancer, as well as cause damage to the DNA, the brain, and the nervous system...
New immunotherapy to fight cancer, keep healthy cells safe
New Delhi: A team of US researchers has developed a new immunotherapy technique that uses cytokine proteins as a potential treatment, effectively targeting tumours without causing harm to healthy cells....
Nestle adds sugar to baby food sold in India but not in Europe
New Delhi: The baby-food brands sold by global giant Nestle in India contain high levels of added sugar, while such products are sugar-free in the United Kingdom, Germany Switzerland, and...
Why India is seeing a rise in oral cancer cases
New Delhi: India bears a significant burden of oral cancers, and the country contributes to about 30 per cent of all global cases, said doctors on Tuesday. April is Oral...
Why India is seeing a rising trend of diseases
New Delhi: Increased stress in life and a sedentary lifestyle combined with a spike in consumption of junk food, smoking tobacco, and alcohol is behind the surging cases of diseases...
This vaccine helped over 50 pc of people remain UTI-free for years
New Delhi: More than 50 per cent of people remained Urinary Tract Infection (UTI)-free for up to nine years who received the oral spray-based vaccine 'MV140', a new study has...
Tingling, burning, numbness in your feet? It can be a sign of prediabetes
New Delhi: If you are regularly experiencing tingling, burning, numbness, and pain in your feet, you may be prediabetic -- a sign that your body’s insulin levels are rising, said...
President Droupadi Murmu unveils 1st ‘India-made’ affordable gene therapy for cancer
New Delhi: In a ray of hope for millions suffering from cancer, President Droupadi Murmu on Thursday unveiled the country’s first indigenously-made and affordable gene therapy for the deadly disease....
Centre calls media reports on hike in medicine prices ‘false & misleading’
New Delhi: The Union Ministry of Health and Family Welfare on Wednesday said that media reports claiming a significant hike in medicine prices are “false, misleading and malicious”. Some media...
Mumbai doctors save micro-preemie baby born at 23 weeks weighing 620 grams
Mumbai: In a rare case, doctors here have given a new lease of life to a micro-preemie baby girl born at 23 weeks, weighing just 620 grams. Micro-preemies are babies...
